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EXPERIMENTAL MELANIN-PROTEIN INDUCED UVEITIS
(EMIU) IS THE SOLE TYPE OF UVEITIS EVOKED
BY A DIVERSITY OF OCULAR MELANIN 
PREPARATIONS AND MELANIN-DERIVED
SOLUBLE POLYPEPTIDES
René M. BROEKHUYSE, Eleonora D. KUHLMANN and Huub J. WINKENS
Summary: Experimental melanin-protein induced uveitis (EMIU) is a CD4 T cell-mediated 
disease involving the choroid and iris, but sparing the retina* The present study was designed to 
solubilize uveitogenic antigen from melanin granules without enzymatic digestion, and to investigate 
some of its elements by comparison with different purified melanin preparations. Many melanin 
surface-derived polypeptides with molecular weights ranging from 1 to >100 kDa were obtained by 
extractions of the prepurified granules with hot lithium dodecyl sulfate (LDS). The mixture was 
electrophoretically separated into seven subfractions, each containing many components and 
capable of evoking the typical features of EMUJ after footpad immunization of Lewis rats. The five 
low-molecular-weight fractions between M, 1 kDa and 30 kDa exhibited most pathogenicity which 
was evenly distributed among the fractions. Highly uvei to genic material remained in the melanin 
preparations even after multiple exhaustive extractions with LDS, and represented about 70% of the 
detectable protein. The uveal pathogen (UP-X) thus proved to be antigenically stable, and the major 
part of the pathogenic material was strongly bound to the granule surface layer. Concentrated urea 
solution was also capable of extracting many uveitogenic melanin polypeptides, but in a different 
composition than LDS did, and less effectively. Human choroidal melanin provided an LDS-soluble 
fraction with low pathogenicity. A single intraperitoneal injection of bovine melanin polypeptides 
together with pertussis toxin, but without footpad immunization in Freund’s complete adjuvant, 
evoked EMIU as well. In all experiments, no uveitis except EMIU was observed, indicating that only 
one type of uveitogenic epitope was present in a wide variety of carrier molecules. An explanation for 
this phenomenon is discussed.
Key Words: Experimental autoimmune anterior uveitis (EAAU)i experimental melanin-protein
induced uveitis (EMIU)3 immunization technique, melanin, uveitogenic melanin 
polypeptides
Introduction
The inflammatory processes of the human 
uvea have long been studied using experi­
mental autoimmune uveoretinitis induced by 
retinal photoreceptor antigens in several 
animal species12-15. The model produced a
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variety of inflammatory phenomena but 
retinitis with the elimination of retinal 
photoreceptor cells was the most striking, 
consistently observed feature. Two essen­
tially new models for CD4 T cell-mediated 
autoimmune uveitis have recently been 
developed: experimental melanin-protein- 
induced uveitis (EMIU), also called experi­
mental autoimmune anterior uveitis (EAAU); 
and experimental autoimmune posterior 
uveitis (EAPU) which is evoked by a retinal 
pigment epithelial membrane antigen PEP- 
65, and includes a typical form of uveoretini-
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tis with extending Dalén-Fuchs nodules3.
EMIU can be effectively induced by im­
munization with purified melanin granules 
isolated from bovine retinal pigment epi­
thelium (RPE)2'3, choroid or iris1’6,10. CD4 
lymphocytes have been shown by immuno- 
histochemical studies to be predominantly 
infiltrating cells. ICAM-1 and major histo­
compatibility complex class II appeared to 
become upregulated just before this infiltra­
tion10’18. The most remarkable feature of 
EMIU is that it includes choroiditis and 
iridocyclitis but usually spares the retina, as 
in noninfectious human acute anterior uvei­
tis. In the search for the essential structural, 
molecular elements responsible for EMIU, 
we studied the pathogenicity of purified 
melanin preparations, and detergent- and 
urea-soluble antigens from bovine and 
human melanin.
Materials and Methods
Antigens
Melanin granules were prepared from 
bovine and human choroid6 (flow chart, 
Figure 1). The vitreous body and retina were 
removed from the posterior part of pig­
mented cow or human eyes. The eyes had 
been stored for 3 hours, and 24 hours5
EYE CUP
dissect
CHOROIDS
rub, sieve
CRUDE MELANOSOMES
2% Triton X-100 (37°C, 5 times)
CHOR(m)TI — (7M urea) 
1 % LDS (75°C, once)
*
CHOR(m)TI-LI -
1% LDS (75°C, 3 times)
CHOR(m)TI -LI/4
+
CHOR(m)TI-US
CHOR(m)TI-UI
CHOR(m)TI-LS
electrophoresis
Fractions A-G
Figure 1. Flow chart of Triton X-100 (T), LDS (L), 
and urea (US)-soluble (S), and insoluble (I) 
melanin (m)-proteins and fractions prepared 
from choroidal (Chor) melanosome prepara­
tions described in text. Injected preparations are 
marked with asterisks.
respectively, at 4°C. The eye cup was rinsed 
with phosphate-buffered saline (PBS) (pH 
7.4), and the choroid was removed with 
forceps. Collected choroids were rubbed in 
an unglazed mortar with minimal added 
PBS; the resulting suspension was filtered 
through gauze. This process was repeated 5 
times on the retained tissue. The combined 
filtrates were centrifuged at 10 000 x g (10 
minutes, 4°C), and the sedimented crude 
melanosomes were washed once with PBS. 
This material was purified by extraction with 
20 volumes (vol/vol) 2% Triton X-100 in 
distilled water at 37°C for 5 hours. The 
extraction was repeated 4 times to remove 
uveitogenic S-antigen and opsin originating 
from retinal remnants. The efficiency of the 
purification of the product, Chor(m)TI was 
checked by sodium dodecyl sulphate-poly- 
acrylamide gel electrophoresis (SDS-PAGE) 
of lithium dodecyl sulphate (LDS) extracted 
protein (obtained as described below), fol­
lowed by immunoblotting with rabbit anti­
sera to S-antigen, interphotoreceptor retinol 
binding protein (IRBP) and opsin2,3. These 
antigens were undetectable in the prepara­
tions used.
The purified Triton-insoluble choroidal 
melanin, Chor(m)TI, was extracted by 1% 
LDS in distilled water at 75°C for 2 hours. 
In pilot experiments, it had appeared that 
the recovery of (unaggregated) protein was 
optimal at 75°C, while higher LDS concen­
trations did not extract larger amounts of 
protein. The extract obtained was dialyzed 
against distilled water at 4°C for 24~48 
hours, and concentrated to a suitable volume 
by freeze-drying.
This procedure lowered the LDS concen­
tration to less than 0,06%, as was needed to 
obtain stable adjuvant emulsions in the im­
munization procedure (described below).
*
The LDS concentration was determined 
according to Hayashi’s method17. A small 
amount of insoluble material was removed 
by centrifugation, and the supernatant con­
taining the bovine LDS-soluble protein was 
called Chor(m)TI-LS. The extracted gran-
Vol. 40 No. 4 UVEITOGENIC MELANIN ANTIGEN 461
ules were labeled Chor(ra)TI-LI (Figure 1). 
The LDS-soluble protein obtained from 
human choroidal melanosomes was labeled 
HuChor(m)TI-LS. Exhaustively extracted 
melanin, Chor(m)TI-LI/4, was prepared as 
the LDS-insoluble bovine melanin by 4 con­
secutive LDS treatments at 75°C for 24 hours. 
The volume ratio of detergent solution to 
melanin sediment was 20:1 in all extractions. 
A urea-soluble fraction was obtained by ex­
tracting Chor(m)TI with 20 volumes 7 mol 
urea-0.1 mol phosphate buffer (pH 7.0) at 
37°C for 2 hours. After centrifugation, the 
supernatant was dialyzed against 0.005 mol 
phosphate buffer-0.05% SDS at 4°C for 
24 hours. The preparation, Chor(m)TI-LS 
(Figure 1), was concentrated by freeze-drying 
to a suitable volume.
Soluble protein and melanin-protein de­
terminations, electrophoretic and immuno- 
blot techniques, antigen and corresponding 
antiserum preparation and checks for anti­
gen purity have been described previously2,3'6. 
Melanin samples for analytical gel electro­
phoresis were kept in 5% SDS-0,1 mol DTT at 
22°C for 3 hours, and the 1.3 x 10 000 x g 
supernatant was added after centrifugation 
(5 minutes, 22°C). Water soluble proteins 
(marker proteins) and LDS- or urea-solu­
bilized proteins were treated similarly, with­
out centrifugation. LDS and SDS could be 
interchanged in the extraction procedures 
without loss of protein recovery, however 
LDS was preferred because of its better 
solubility and dialysis characteristics at low 
temperature.
Detergent-soluble polypeptides from 
Chor(m)TI-LS were separated and isolated 
by prior SDS-PAGE using Tris-Tricine buffer, 
according to Schägger et al22. We used the 4% 
and 16.5% acrylamide plus bisacrylamide 
concentrations for the stacking and separat­
ing gel, respectively, while the cross-link 
concentration was 3% in both gels. No spacer 
gel was used. The gels were then stained by 3 
mol CuClj solution19. The polypeptides were 
isolated from the excised gel bands in an
electro-eluter (Model 422, Bio-Rad, Burlin­
game, CA, USA) following the manufacturer’s 
protocol. Protein was precipitated and freed 
from almost all detergent by 9 volumes cold 
acetone (0°C). The sediment was dissolved in
a suitable volume of distilled water. Protein 
was determined according to Lees and 
Paxman20. Molecular weights were estimated 
by graphic extrapolation, using sets of high 
and low molecular weight proteins22. LDS 
was obtained from Serva (Heidelberg, Ger­
many); prestained molecular weight calibra­
tion proteins from Novel Experimental Tech­
nology (San Diego, CA, USA); and the 
markers and other (bio)chemicals from 
Sigma (St Louis, MO, USA).
Experimental uveitis
Female Lewis rats (130~180 g) were im­
munized with the melanin preparations 
described (10—15 jug), detergent and urea 
extracts from melanin (50~150 fig), and the 
purified polypeptide fractions (75~150 /ng), 
according to the protocol of Broekhuyse et 
als. The toxin dose was doubled to 2 fig in 
order to detect weak pathogenicity more 
easily. Table 1 shows experimental data. Half 
the antigen dose emulsified in Freund’s com­
plete adjuvant was injected into the hind 
footpads (0.1 mLper pad); the rest was mixed 
with 2 fig purified pertussis toxin (Sigma) in a 
final volume of 1 mL phosphate-buffered 
saline, and injected intraperitoneally. Control 
animals were similarly injected without 
antigen. In an alternative protocol, 75 fig 
Chor(m)TI-LS in a 1 mL volume of Freund’s 
incomplete adjuvant emulsion was intraperi­
toneally injected with 2 jug pertussis toxin, 
without footpad immunization.
Pertussis toxin was stored at —80°C in 
ready-to-use portions, in 50% glycerol-50 
mM sodium phosphate - 0.5 M NaCI (pH 7.2).
It was tested for adjuvant activity before 
each experiment by immunizing 5 rats with 
Chor(m)TI-LI (10 jug per rat), according to 
the footpad injection protocol, using 1 fig 
toxin. The same antigen preparation was 
used throughout all activity tests. The toxin 
adjuvant was rejected if the group of animals 
did not develop severe EMIU (score 4) within
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Table 1. Experimental uveitis evoked by footpad immunization with melanin-protein
preparations or polypeptides solubilized from ocular melanin
Injected
polypeptides*
Dose
(ms)
Rats with uveitist 
Incidence Mild Severe
Uveitis
features
Maximum
scoret
Day of 
onsetî
From Chor(m)TI-LS
Chor(m)Tï-LS 50 4/4 0 4 EMIU >4.0±0.0 11.5±0.3
40-200 kDa 120 1/3 0 1 EMIU§ 4.0 27
30—40 kDa 120 1/3 0 1 EMIU 4.0 21
18-30 kDa 120 3/3 0 3 EMIU 4.0±0.0 11.5±0.5
15-18 kDa 80 5/5 0 5 EMIU >4.0±0.0 10.8±0.2
13-14.5 kDa 75 2/2 0 2 EMIU§ 4.0+0.0 15,18
6-12 kDa 75 5/5 0 5 EMIU >4.0±0.0 12.5±0.1
1—6 kDa 110 2/2 0 2 EMIU >4.0±0.0 11,12
Other
Chor(m)TI-US 110 3/3 0 3 EMIU 4.0±0.0 12.3±0.2
Chor(m)TI-LI/4 10 4/4 0 4 EMIU 4.0±0.0 12.3±0.3
HuChor(m)TI-LS 150 2/3 2 0 EMIU 2.0+0.0 12,27
Controls 0 0/5 0 0 ----------- -----------
*Chor(m)TI-LS and Chor(m)TI-US, LDS-soluble and urea-soluble fractions of Triton X-100-insoluble 
bovine (or human, Hu) choroidal melanin granules. 40~200-KDa etc, polypeptide fractions isolated 
from Chor(m)TI-LS.
tMild, score 1-2; severe, score >3
ÎMean values ± SEM. Score >4, blood was present in anterior chamber, and prominence of eye was 
observed in addition to reported features of EMIU.
§ Mainly iritis
12 days after immunization.
The development of uveitis was studied by 
daily slit-lamp examination, and was scored 
in a masked fashion starting on day 9 after 
immunization. The severity was recorded 
using the scoring systems for EMIU (EAAU) 
on a scale of 0~42. The eyes and pineal 
glands were fixed in Bouin solution within 4 
days after the maximum score was reached, 
and processed using standard histological 
techniques. Six-micron paraffin sections were 
stained with hematoxylin and eosin, and 
examined by light microscopy. In conducting 
the research described in this report, the 
investigators adhered to the “Guide for the 
Care and Use of Laboratory Animals” (NIH,
USA)16.
Results
Polypeptides eliciting EMIU
A single hot LDS extraction of Triton- 
purified bovine choroidal melanin removed 
a complex mixture of surface proteins from
the granules, Chor(m)TI-LS, with a protein 
recovery of 20% relative to Chor(m)TI pro­
tein. Concentrated urea solution also dis­
solved a mixture of polypeptides, Chor(m)TI- 
US, but with a low protein recovery (4%). 
Figure 2 shows that the polypeptide composi­
tions of the US and the LS extracts differed. 
Urea did not extract the three components 
between the 14 and 17 kDa bands of LS. The 
group of 30—40 kDa components of LS was 
nearly absent in US. However, in the >40 
kDa area, many polypeptides were extracted 
which were found in only small amounts in 
LS, around 43 kDa and a ~200 kDa band. 
The polypeptide pattern of the urea-insolu­
ble protein Chor(m)TI-UI (partially dissolved 
in SDS at 22°C for gel electrophoresis) is 
largely complementary to that of the solu­
bilized Chor(m)TI-US. Figure 8 shows that 
even the sample-SDS (for gel electrophoresis) 
is barely capable of dissolving protein from 
Chor(m)TI after 5 Triton X-100 extractions. 
However, the recovery of the hot (LDS) ex-
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Figure 2. SDS-PAGE in Tris-Tricine buffer of 
Chor(m)TI derived preparations. R, low molecu­
lar weight reference proteins (myoglobin frag­
ments M, 17,14.4,10.6,8.2,6.2 and 2.5 kDa, and 
naturally occurring glucagon 3.5 kDa); US, 7 M 
urea-soluble fraction; LS, LDS-soluble fraction; 
UI, urea-insoluble fraction remaining after 
removal of US; HM, high molecular weight 
protein markers: myoglobin (205 kDa), ß- 
galactosidase (116 kDa), serum albumin (68 
kDa), catalase (58 kDa), ovalbumin (43 kDa), 
chymotrypsinogen A (26 kDa), trypsin inhibitor 
(mainband: 21 kDa), and lysozyme (14.5 kDa). 
Twenty micrograms of protein was applied of 
each melanin preparation.
traction is much higher as seen in the 
Chor(m)TI-LS lane. The same is true for 
HuChor(m)TI-LS. This solubilized human 
melanin-protein exhibited a different poly­
peptide pattern, but the 14—IV kDa and 
55~60 kDa bands were remarkably similar in 
composition and prominence to the (bovine) 
Chor(m)TI-LS. Because of the pre-extrac­
tions with LDS at 75°C during preparation,
no further protein could be dissolved from
Chor(m)TI-LI or Chor(m)TI-LI/4 at 22°C
with the analytical gel electrophoresis tech­
nique described above. Consequently, these 
fractions are not included in Figures 1~3.
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Figure 3. SDS-PAGE in Tris-Tricine buffer of 
50 /¿g (melanin-protein) bovine Chor(m)TI 
(TI), 25 fig Chor(m)TI-LS (LS), 25 /<g human 
Chor(m)TI-LS (HLS) and prestained markers 
(PM): myosin (250 kDa; at top of gel), bovine 
serum albumin (98 kDa), glutamic dehydro­
genase (64 kDa), alcohol dehydrogenase (50 
kDa), carbonic anhydrase (36 kDa), myoglobin 
(30 kDa), lysozyme (16 kDa), apoprotein (6 kDa), 
and insulin B chain (4 kDa; weak band) 
(molecular weight values deviate from normal 
after prestaining).
Uveito genicity of extracts
Solubilized choroidal melanin proteins 
Chor(m)TI-LS and Chor(m)TI-US were used 
for the immunization of Lewis rats. They 
proved to be highly pathogenic at the 50 and 
110 /¿g level, respectively, and evoked severe 
EMIU starting about 12 days after immuniza­
tion (Table 1). A similar result (not shown in 
Table 1) was obtained if the whole dose of 
Chor(m)TI-LS (75 fug) was injected intra- 
peritoneally, but EMIU started at day 14. 
The solubilized human melanin protein 
HuChor(m)TI-LS exhibited low uveitogen-
icity (Table 1 ).
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Figure 4. SDS-PAGE in Tris-Tricine buffer of the polypeptide fractions isolated by preparative gel elec­
trophoresis of hot LDS-extracted protein of purified bovine choroidal melanin, Chor(m)TI-LS.
A, 40-200 kDa; B, 30-40 kDa; C, 18-30 kDa; D, 15-18 kDa; E, 13-14.5 kDa; F, 6-12 kDa; 
G, 1—6 kDa; H, Chor(m)TI-LS; R, reference proteins, molecular weights indicated.
Uveitogenicity of fractions
Seven polypeptide fractions were isolated 
from the LDS extract of choroidal melanin 
granules by prior SDS-PAGE (Figure 4). A 
brown pigment band (Mr< l kDa) running 
ahead of the polypeptides (not shown) was 
similarly isolated. The relative recoveries of 
the fractions were 19% for 40~200 kDa, 13% 
for 30~40 kDa, 15% for 18~30 kDa, 11% for 
15-18 kDa, 14% for 13-14.5 kDa, 11% for 
6~12 kDa and 16% for 1~6 kDa. The five low 
molecular weight Chor(m)-polypeptide frac­
tions between 1—30 kDa (Table 1) most 
effectively evoked the typical features of 
EMIU in all animals, clinically as well as 
histopathologically. The frequency of EMIU 
was lower for the higher molecular weight 
fractions (40—200 kDa) and the day of onset 
was later (Table 1); cell infiltrations were 
moderate. The pigmented band of the very
low molecular weight (<1 kDa) exhibited no 
uveitogenicity. After 4 lengthy hot LDS ex­
tractions of Chor(m)TI, a highly uveitogenic 
melanin preparation, Chor(m)TI-LI/4, that 
still contained about 70% of the originally 
detectable Chor(m)TI-protein, was obtained. 
Clinical features 
Slit-lamp examination revealed the de­
velopment of bilateral acute, severe to very 
severe, anterior uveitis starting between days 
10 and 18 after immunization. The clinical 
features were extensive iris hyperemia ac­
companied by dense flare and cells obscur­
ing view of the fundus. In very severe uveitis, 
blood entered the anterior chamber and the 
eye protruded. The consistently high slit- 
lamp scores (Table 1) show that the develop­
ment of EMIU always resulted in severe 
inflammation although the onset in a few 
animals could be as late as day 21 or 27 after
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Figure 5. EMIU (day 15 after immunization) 
evoked by immunization of Lewis rats with 15~ 
18 kDa polypeptides from bovine Chor(m)TI-LS. 
Very severe iridocyclitis with predominantly 
mononuclear cells in anterior uvea (x360).
immunization.
Histopathology
Histopathological examination of the eyes 
revealed severe uveitis, generally sparing the 
retina as is characteristic for EMIU. Pinealitis 
was absent. The details of the inflammatory 
pattern have been described previously2’®. 
The eyes in the present experiments ex­
hibited marked variability in the intensities 
of posterior and anterior uveitis. Choroiditis 
generally varied from mild to moderate (in 
some cases, severe) while iritis was usually 
severe to extremely severe. In the latter cases, 
the ciliary body, especially the iris, was highly 
dystrophic. Dense, largely mononuclear cell 
infiltrations were present throughout the 
entire anterior uvea. A few days after onset, 
many polymorphonuclear cells were found
around the anterior uvea which was very 
swollen. The cell infiltrations often formed 
nodules where the epithelia had been dis­
rupted (Figure 5). Although the retina was 
usually not affected in the primary process, a 
mononuclear cell infiltration was occasion­
ally found in the outer retina disturbing or 
destroying the photoreceptor cells and outer 
nuclear layer.
Discussion
It has recently been demonstrated that 
strong uveitogenicity resides at the surface of 
ocular melanin granules, and that it is not 
due to pathogenic photoreceptor proteins 
like S-antigen, IRBP or rhodopsin. Acid 
digestion or phagocytosis by macrophages 
destroys this strong pathogenicity while the 
granules themselves remain intact. Alkaline 
solutions dissolve the melanin and destroy its 
pathogenicity, but an apolar detergent like
Triton X-100, and polar detergents like LDS 
(and SDS) leave the granule virtually intact, 
although dissolving some melanin-associated 
protein3'6'7. Previous investigations in our 
laboratory showed that Triton X-100 (at 37°C) 
was able to remove the residues of adhering 
ocular tissue proteins, including traces of 
photoreceptor proteins originating from the 
RPE2,3,B. Because of the abundant presence of 
rod outer segment membranes in the RPE, 
traces of opsin could sometimes be detected 
in Chor(m)TI, but such preparations were 
excluded for further work. In view of the 
absence of opsin, and the water-soluble 
photoreceptor antigens (S-antigen and IRBP) 
we have assumed that other known soluble 
pathogens (ie, phosducin12 and recoverin18) 
were also lacking in Chor(m)TI. The absence 
of photoreceptor damage as a major, primary 
event, (since it is evoked by all photoreceptor 
proteins) shows that this assumption is a 
valid one. The Triton X-100 treatment was 
still mild enough to leave behind the major 
part of the uveitogenic protein that is more 
firmly bound to the granules, but that can be 
dissolved by LDS, SDS, or by 7 mol urea. Pilot 
experiments also showed that the polar
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detergents exhibited optimal dissolution 
properties at 75°C for 2 hours. A longer
extraction period resulted in increasing ag­
gregation of the polypeptides as revealed by 
SDS gel electrophoresis (not shown) while 
shorter extraction lowered the recovery. The 
determination of the recovery of LDS-soluble 
and LDS-insoluble protein was based on a 
previously elaborated melanin-protein assay 
in which the dissolution of disturbing brown 
pigment was largely prevented8. This method 
enabled comparison of the applied immuni­
zation doses of melanin-bound protein and 
detergent-solubilized protein. It appeared 
that up to 20% of the surface melanin-protein 
could be removed from the granules in the 
preparation protocol for Chor(m)TI-LS poly­
peptides; our present results indicate about 
30% can be removed by the exhaustive 
extraction technique. The efficiency of the 
applied dissolution technique demonstrates 
that many uveitogenic polypeptides can be 
obtained in this way without the use of 
proteolytic enzymes. The smaller fragment 
obtained by digestion1 favors structural 
analysis of the active epitope; the soluble 
peptides may in addition reveal more exten­
sive molecular structural details. 
Uveitogenicity of melanin preparations
The results in Table 1 show that 50 jig 
Chor(m)TI-LS protein is as uveitogenic as 10 
fig Chor(m)TI-LI/4. The latter represents a 
preparation of LDS-treated melanin granules 
with strongly bound residual protein (70%) 
that cannot be removed by 4 LDS extractions 
at 75°C for 24 hours. This highly uveitogenic 
protein is probably covalendy bound to the 
granule surface and has been reported to be 
uveitogenic even at doses as low as 1 /üg6.
Other laboratories have also recently 
demonstrated the uveitogenicity of ocular 
melanin and the unique pattern of inflam­
matory reactions it produces. Twenty-five 
micrograms dry-weight purified choroidal 
melanin granules10, corresponding to 10 jig 
melanin-protein, according to Broekhuyse et 
al6, or 100 or 200 jig iris-ciliary body-derived 
melanin protein1'18 induced severe EMIU.
Differences were reported in the severity of 
choroiditis in these studies. Whereas we 
originally reported2'3 severe iridocyclitis and 
mild to moderate choroiditis (as Bora et al1), 
Chan et al10 reported both marked iridocycli­
tis and marked choroiditis. Our present re­
sults show that if high doses of an appro­
priate antigen are used, combined with 2 /ig 
high-potency pertussis toxin, very severe 
iridocyclitis (score >4) is a dominant feature 
of EMIU (Table 1; Figure 3). The relative
severity of anterior inflammation with respect 
to choroiditis might be ascribed to these dose 
dependencies of the EMIU characteristics. In 
addition, we noticed that pertussis toxin 
stored at —20°C lost appreciable adjuvant 
activity during a period of 2~3 months. 
Storing the toxin at ultra-low temperature 
and avoiding freeze-thawing largely pre­
vented loss of adjuvant activity (Ref 2; unpub­
lished results; present results).
Table 1 also shows that the majority of the 
pathogenic activity can be ascribed to the low 
molecular weight polypeptides (1~30 kDa). 
Only one type of uveitis (EMIU) developed in 
all experiments after immunization with the 
great variety of soluble as well as insoluble 
(granular melanin) antigens. The numerous 
components suggest that this diversity results 
from extensive variation in the dimension of 
the molecule(s) carrying the uveal pathogenic 
melanin-peptide UP-X. The composition of 
melanin may encourage structural diversity 
because it is basically composed of polymeric 
chromophoric backbones: oxidized deriva­
tives of tyrosine-bearing (presumably) co­
valently bound protein11'21. The carrier mole­
cules may be, or contain, (partially) homolo­
gous melanin-derived structures. The finding 
that only a relatively small proportion of the 
pathogenic melanin-protein can be solu­
bilized (Refs 3, 6; present results) indicates 
that the pathogenicity is primarily repre­
sented by the bound protein. The LDS- 
solubilized fraction exhibits the same type of 
pathogenicity as the bound protein, and may 
represent the part that is not (yet) covalently 
bound. In addition, or alternatively, the
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melanin granule surface may associate 
pathogenic environmental cell components 
which may also be present, if no (mature) 
melanin granules are formed. The weak 
uveitogenicity of isolated bovine amelanotic 
RPE fractions3 or other amelanotic prepara­
tions1 seem to exclude this possibility.
Uveitogenicity is not restricted to ocular 
melanin since partially purified bovine skin 
melanin also exhibits this activity6. The find­
ing that intraperitoneal immunization with 
solubilized melanin antigen (without the use 
of adjuvant bacteria) also induces EMIU 
agrees with a previous study of this tech­
nique, However, injection of the granular 
melanin-bound antigen proved to be much 
more effective8. Only 5 //g melanin-protein 
was needed to confirm the high uveitogen­
icity of the granules. The relative efficiency 
of this immunization route resulted from the 
effective processing of the granular antigen
by macrophages.
In  conclusion, our results show that the 
EMIU-evoking melanin antigen UP-X can be 
dissolved from pre-purified melanin granules 
by hot LDS. The major part of the pathogenic 
activity remains bound. The soluble poly­
peptides obtained vary widely in molecular 
weight, and still exhibit uveitogenicity, espe­
cially in the 1—30 kDa range. Since no 
inflammatory pattern other than EMIU was 
detected, it appears that UP-X is the sole 
pathogen on the melanin granule surface.
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